Introduction
============

The heart adapts to changes in its physiologic environment, initially through alterations in the activity state and/or locality of pre-existing proteins within the cardiomyocyte. Chronic activation of intracellular signaling cascades affect the levels of specific proteins in the cell, through transcriptional, translational and post-translational mechanisms. For example, increased workload acutely increases glycogenolysis, glucose transport, and lactate oxidation, with a lesser effect on fatty acid oxidation ([@b18-grsb-2007-251]). Persistence of pressure overload on the heart results in sustained alterations in metabolism as a consequence of changes in the expression of proteins involved in glucose and fatty acid utilization ([@b1-grsb-2007-251]).

Sustained pressure overload not only affects substrate preference, but also leads to a remodeling of the heart. Cardiomyocytes increase in size (hypertrophy), together with alterations in the expression of multiple myocardial genes ([@b23-grsb-2007-251]; [@b35-grsb-2007-251]). In the latter case, the hypertrophied heart reverts to a fetal pattern of gene expression, wherein various fetal genes are induced with a concomitant repression of adult genes ([@b24-grsb-2007-251]; [@b9-grsb-2007-251]). One example is the switching of *mhc* isoforms, in which *mhcβ* (the fetal isoform) is induced, while *mhcα* (the adult isoform) is repressed in the hypertrophied rat heart ([@b9-grsb-2007-251]; [@b26-grsb-2007-251]). The exact mechanism(s) by which this isoform switching occurs is (are) not known. It is an intriguing observation that sustained decreases in work load or sustained changes in the metabolic milieu (e.g. insulin deficient diabetes mellitus) induce a similar patter of isoform switching ([@b9-grsb-2007-251]; [@b11-grsb-2007-251]; [@b10-grsb-2007-251]).

The purpose of the present study was to explore the hypothesis that substrate metabolism and/or intracellular metabolites are responsible for *mhc* isoform switching in the heart in response to stimuli such as pressure overload. More specifically, we hypothesized that accumulation of intramyocellular glucose metabolites drives *mhc* isoform switching in the hypertrophied heart. This hypothesis was investigated by: 1) increasing glucose influx into the heart *ex vivo*; 2) increasing glucose influx into the heart *in vivo*; 3) attenuating increased glucose influx by the heart during pressure overload-induced hypertrophy *in vivo*; and 4) investigating potential glucose sensing components in both the normal and pressure overloaded heart. The results are consistent with the notion that alterations in glucose metabolism play a role in *mhc* isoform switching.

Methods
=======

Animals and dietary interventions
---------------------------------

Rats: Male Spraque-Dawley rats were kept in the Animal Care Center of the University of Texas-Houston Medical School. Mice: Male wild-type and MHCα-GLUT1 transgenic littermates with cardiac-specific overexpression of GLUT1 were kept in the Animal Resource Facility at Harvard Medical School. All rodents were housed under controlled conditions (23 ± 1 °C; 12 h light/12 h dark cycle) and received chow and water *ad libitum*. The investigations conformed to the *Guide for the Care and Use of Laboratory Animals* published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Rodents were fed one of three isocaloric diets; standard laboratory chow (Purina), a high carbohydrate/low fat diet (HC/LF; Research Diets Inc., New Brunswick, NJ), or a low carbohydrate/high fat diet (LC/HF; Research Diets Inc., New Brunswick, NJ). Because the latter two diets were isocaloric, they varied only in the proportion of energy obtained from carbohydrate and fat. For the rat studies, the contribution of carbohydrate, fat and protein to total energy available were 71%, 6% and 23% for the HC/LF diet, and 24%, 53% and 23% for the LC/HF diet, respectively. For the mouse studies, the contribution of carbohydrate, fat and protein to total energy available were 70%, 10% and 20% for the HC/LF diet, and 20%, 60% and 20% for the LC/HF diet, respectively. The fat component consisted chiefly of lard (saturated, long-chain fatty acids). All other animals were fed the standard laboratory chow.

Working heart *ex vivo*
-----------------------

Isolated rat hearts were perfused for 90 min in the working mode (15 cm H~2~O preload/100 cm H~2~O afterload) with Krebs-Henseleit buffer containing β-hydroxybutyrate (10 mM), acetoacetate (1 mM) and propionyl-L-carnitine (2 mM). In certain experiments, glucose (25 mM) was added to the perfusate. Mannitol (25 mM) was added to the perfusate when glucose was absent. A physiologic concentration of insulin (40 μU/ml; Lilly) was included in all perfusions. At the end, hearts were freeze-clamped and stored in liquid nitrogen. This method has been described in detail elsewhere ([@b36-grsb-2007-251]).

Ascending aortic constriction *in vivo*
---------------------------------------

Cardiac pressure overload was induced by constriction of the ascending aorta ([@b23-grsb-2007-251]). In control animals, sham operations were performed. During the seven days before surgery, the animals received either standard laboratory chow (control diet), the HC/LF diet, or the LC/HF diet. Specific feeding was maintained until the completion of the experiment (i.e. isolation of hearts), either nine days (HC/LF and LC/HF feeding studies) or seven weeks (standard laboratory chow studies) after surgery. The effects of banding and altered dietary fat content on body weight and heart weight are shown in [Table 1](#t1-grsb-2007-251){ref-type="table"}.

RNA isolation and quantitative RT-PCR
-------------------------------------

RNA extraction and quantitative RT-PCR of samples was performed using previously described methods ([@b9-grsb-2007-251]; [@b5-grsb-2007-251]; [@b15-grsb-2007-251]). Specific quantitative assays were designed for *mhcα*, *mhcβ*, *gfat1*, *gfat2*, glucose 6-phosphate dehydrogenase (*g6pdh*), and transketolase (*tkl)* using rat and mouse sequences available in GenBank ([Table 2](#t2-grsb-2007-251){ref-type="table"}). Primers and probes were designed from non-conserved sequences of the genes (allowing for isoform specificity), spanning sites where two exons join (splice sites), preventing recognition of the assay to any potential contaminating genomic DNA. Standard RNA was made for all assays by the T7 polymerase method (Ambion, Austin, Texas), using total RNA isolated from rat hearts. The correlation between the C~t~ (the number of PCR cycles required for the fluorescent signal to reach a detection threshold) and the amount of standard was linear over at least a 5-log range of RNA for all assays (data not shown). PCR data are reported as the number of mRNA transcripts per ng total RNA.

UDP-N-Acetylglucosamine
-----------------------

The levels of UDP-N-acetylglucosamine, the major end product of the hexosamine biosynthetic pathway, were measured in perchloric acid extracts of rat heart homogenates using high-performance liquid chromatography and spectrophotometry as previously described ([@b41-grsb-2007-251]).

Xylulose 5-Phosphate
--------------------

Myocardial levels of the pentose phosphate pathway (PPP) intermediate xylulose 5-phosphate were measured using a spectrophotometric assay similar to that described previously for the liver ([@b3-grsb-2007-251]). Briefly, deproteinized heart samples were prepared by homogenizing approximately 400 mg of powdered heart with 5.6% perchloric acid (2 mls). Following neutrilization, xylulose 5-phosphate levels were measured in PCA extracts by following NADH generation via the combined transketolase and glyceraldehyde 3-phosphate dehydrogenase reactions.

Statistical analysis
--------------------

Data are presented as the mean ± SEM for between four and ten hearts in each group. Statistically significant differences between groups were calculated by analysis of variance (ANOVA). A value of p \< 0.05 was considered significant.

Results
=======

Glucose induces *mhc* isoform switching *ex vivo*
-------------------------------------------------

To determine whether glucose induced *mhc* isoform switching in hearts under controlled conditions *ex vivo*, the isolated working rat heart preparation was utilized. Working rat hearts from animals fed a standard laboratory chow diet were perfused either in the absence or presence of glucose (25 mM). In the former case, mannitol (25 mM) was added to the perfusate to allow for any osmotic effects of glucose on heart function and/or gene expression. A trend for lower levels of *mhcα* mRNA was observed for hearts perfused in the presence of glucose compared to those perfused in the presence of mannitol, although this did not reach statistical significance ([Fig. 1A](#f1-grsb-2007-251){ref-type="fig"}). However, *mhcβ* mRNA levels were significantly elevated in hearts perfused with glucose, compared to those perfused with mannitol ([Fig. 1B](#f1-grsb-2007-251){ref-type="fig"}). The *mhcα*/*mhcβ* ratio (a marker of isoform switching) was significantly lower in glucose-perfused hearts ([Fig. 1C](#f1-grsb-2007-251){ref-type="fig"}).

Glucose induces *mhc* isoform switching *in vivo*
-------------------------------------------------

To investigate whether glucose induced *mhc* isoform switching occurs *in vivo,* we utilized mice with a cardiomyocyte-specific overexpression of the glucose transporter GLUT1; hearts from these mice, which have been characterized previously ([@b25-grsb-2007-251]), do not exhibit contractile dysfunction. Hearts isolated from transgenic mice fed the HC/LF diet exhibit significantly lower *mhcα* expression, with a concomitant greater *mhcβ* expression, compared to hearts isolated from wild-type littermates, fed the same diet ([Figs. 2A--2B](#f2-grsb-2007-251){ref-type="fig"}). Feeding mice the LC/HF diet prevented this isoform switching; *mhcα* expression was not significantly different between wild-type and transgenic mice fed the LC/HF diet, whereas *mhcβ* was significantly lower in hearts isolated from transgenic versus wild-type mice fed the LC/HF diet ([Fig. 2B](#f2-grsb-2007-251){ref-type="fig"}). As such, *mhc* isoform switching (*mhcα*/*mhcβ* ratio) observed for hearts isolated from transgenic mice was prevented when mice were fed the LC/HF diet ([Fig. 2C](#f2-grsb-2007-251){ref-type="fig"}).

Limiting dietary carbohydrate availability prevents *mhc* isoform switching in response to pressure overload
------------------------------------------------------------------------------------------------------------

We have shown before that nine days of aortic constriction induces left ventricular hypertrophy in rats fed either HC/LF or LC/HF diet (i.e. diet-independent); diet alone had no effects on body weight, or heart weight ([@b46-grsb-2007-251]). The same was the case in the present study ([Table 1](#t1-grsb-2007-251){ref-type="table"}).

Aortic constriction of animals placed on the HC/LF diet resulted in decreased *mhcα* mRNA levels ([Fig. 3A](#f3-grsb-2007-251){ref-type="fig"}), and a concomitant increase in *mhcβ* mRNA levels ([Fig. 3B](#f3-grsb-2007-251){ref-type="fig"}). This isoform switching was not observed in response to pressure overload when rats were placed on the LC/HF diet ([Figs. 3A--3B](#f3-grsb-2007-251){ref-type="fig"}). Diet alone had no effects on MHC isoform expression in the heart ([Figs. 3A--3B](#f3-grsb-2007-251){ref-type="fig"}, black columns). As such, pressure overload-induced *mhc* isoform switching (as indicated by the *mhcα*/*mhcβ* ratio) was prevented when rats were fed the LC/HF diet ([Fig. 3C](#f3-grsb-2007-251){ref-type="fig"}). We also measured transcript levels of the "fetal" genes basic fibroblast growth factor (*bfgf*) and skeletal α-actin (*sk α-actin*) ([Figs. 3D--3E](#f3-grsb-2007-251){ref-type="fig"}). Like the transcript levels of MHCβ, pressure overload-mediated induction of these two transcripts was attenuated when rats were fed the LC/HF diet.

Sustained pressure overload activates the hexosamine biosynthetic pathway
-------------------------------------------------------------------------

To investigate whether increased flux through the hexosamine biosynthetic pathway occurs in response to pressure overload in the heart, we measured: 1) the expression of two isoforms of GFAT (glutamine fructose 6-phosphate amido-transferase, *gfat1* and *gfat2*) which catalyzes the flux generating step in this pathway; and 2) UDP-N-acetylglucosamine, the principal end-product of this pathway, in control as well as in hypertrophied hearts ([@b41-grsb-2007-251]; [@b44-grsb-2007-251]; [@b31-grsb-2007-251]).

Ascending aortic constriction for seven weeks induced hypertrophy (heart-to-body weight ratios 2.84 ± 0.02 vs 3.69 ± 0.05, control vs banded; p \< 0.001). The level of *gfat1* expression was not significantly different between the control and hypertrophic hearts ([Fig. 4A](#f4-grsb-2007-251){ref-type="fig"}). In contrast, the level of *gfat2* mRNA was 38% higher in pressure overloaded hearts compared to control hearts ([Fig. 4B](#f4-grsb-2007-251){ref-type="fig"}). In addition, pressure overload was also associated with a 40% increase in cardiac UDP-N-acetylglucosamine levels ([Fig. 4C](#f4-grsb-2007-251){ref-type="fig"}).

No effect of sustained pressure overload on the pentose phosphate pathway
-------------------------------------------------------------------------

To investigate whether increased flux through the pentose phosphate pathway occurs in response to pressure overload in the heart, seven weeks after aortic constriction we measured in control and hypertrophied hearts: 1) the expression of two key enzymes in xylulose 5-phosphate biosynthesis, namely *g6pdh* (glucose 6-phosphate dehydrogenase) and *tkl* (transketolase); and 2) xylulose 5-phosphate, an important regulatory intermediate in this pathway. The results indicate that neither the expression of *g6pdh* nor *tkl* were affected by sustained pressure overload ([Figs. 4D--4E](#f4-grsb-2007-251){ref-type="fig"}). Xylulose 5-phosphate levels were also not different ([Fig. 4F](#f4-grsb-2007-251){ref-type="fig"}).

Discussion
==========

We provide strong evidence in support of the hypothesis that glucose metabolites play a role in the adaptation of the myocardium to pressure overload, at the level of gene expression. When hearts are forced to utilize glucose, both *ex vivo* (glucose perfused hearts) and *in vivo* (GLUT1 transgenic mice), *mhc* isoform switching is induced. Limiting dietary glucose prevents *mhc* isoform switching in both GLUT1 transgenic hearts and pressure overload-induced hypertrophied hearts. For potential mechanisms we focused on the hexosamine biosynthetic pathway and the pentose phosphate pathway ([Fig. 5](#f5-grsb-2007-251){ref-type="fig"}). Myocardial levels of *gfat2* mRNA (encoding for a flux generating enzyme in the hexosamine biosynthetic pathway) and UDP-N-acetylglucosamine (the major end-product of this pathway) were elevated in response to pressure overload. In contrast, no alterations in the expression of two key enzymes in the pentose phosphate pathway (namely *g6pdh* and *tkl*) were observed in the hypertrophied heart, nor was there an increase in xylulose 5-phosphate levels.

Glucose sensing in the heart
----------------------------

A hallmark of long-term adaptation of the rodent heart to environmental stresses is the re-expression of a fetal gene program. The predominant isoform of myosin heavy chain (*mhc*) expressed in the fetal heart of the rodent is *mhcβ*. During the first weeks of post-natal life, *mhcβ* declines and is replaced by the adult isoform, *mhcα* ([@b33-grsb-2007-251]). In the presence of chronic stimuli, including pressure overload, mechanical unloading or diabetes, the heart re-expresses *mhcβ* with concomitant repression of *mhcα* expression ([@b9-grsb-2007-251]; [@b26-grsb-2007-251]). To date, no single pathway has been attributed to this isoform switching in the heart to these various stimuli.

We propose a unifying hypothesis that is based on the following reasoning. Despite the apparent opposing metabolic adaptation of the heart to alterations in workload and a diabetic milieu, we propose that glycolytic intermediates accumulate in the heart during both situations due to an imbalance between glucose uptake and phosphorylation on the one hand and pyruvate oxidation on the other hand ([Fig. 5](#f5-grsb-2007-251){ref-type="fig"}). In the hypertrophied heart (and the atrophied and fetal hearts), glucose uptake and metabolism are both increased ([@b1-grsb-2007-251]; [@b13-grsb-2007-251]). However, the high rate of glucose uptake exceeds the rate of pyruvate oxidation, resulting in accumulation of glycolytic intermediates. A similar scenario may occur for the heart during hypoxia, where decreased expression of peroxisome proliferator-activated receptor α-(PPARα-) regulated genes is associated with increased reliance on glucose ([@b30-grsb-2007-251]). We designed the experiments with the assumption that with LC/HF we significantly reduced carbohydrate availability, although neither blood glucose nor insulin levels were measured. Previously published studies have shown lower plasma glucose and insulin levels in the fed state for rats fed a high fat (low carbohydrate) diet ([@b8-grsb-2007-251]). This pattern is markedly different from insulin-dependent diabetes mellitus, where both glucose and fatty acids levels are markedly elevated. In contrast to the hypertrophied heart, the diabetic heart increases reliance on fatty acids as a fuel. Fatty acids inhibit glucose oxidation at the level of the pyruvate dehydrogenase complex (PDC) to a greater extent than they inhibit glucose uptake. Increased mitochondrial acetyl-CoA and NADH levels (due to increased fatty acid and ketone body utilization) and phosphorylation by PDC kinase 4 (due to PPARα-mediated induction) jointly inhibit PDC ([@b43-grsb-2007-251]; [@b29-grsb-2007-251]). Despite decreased glucose transporter expression and decreased insulin-mediated glucose transport, the rates of glucose uptake in the diabetic environment, are comparable to those observed in normal hearts, due to the prevailing hyperglycemia ([@b38-grsb-2007-251]). Thus, with normal glucose influx into the cardiomyocyte, and the block at PDC, glucose metabolites accumulate. Indeed, intracellular concentrations of glucose, glucose 6-phosphate, fructose 6-phosphate, glycogen, pyruvate and lactate have all been shown to be increased in the heart during diabetes ([@b4-grsb-2007-251]; [@b34-grsb-2007-251]).

Additional evidence exists in support of the hypothesis. If the rate of glucose oxidation is increased in the pressure overloaded heart, thereby re-coupling glycolysis and pyruvate oxidation, through treatment of rats with etomoxir, an irreversible inhibitor of carnitine palmitoyltransferase I, *mhc* isoform switching is attenuated ([@b37-grsb-2007-251]). Similar results are observed for the heart in diabetes. Myocardial *mhc* isoform switching during diabetes is prevented by treatment with etomoxir, as well as a second fatty acid oxidation inhibitor, methylpalmoxirate ([@b12-grsb-2007-251]; [@b32-grsb-2007-251]). It therefore appears that whenever there is a loss of coupling between glycolysis and pyruvate oxidation, either due to increased glucose influx (e.g. fetal, hypertrophied and atrophied hearts) and/or inhibition of pyruvate oxidation (e.g. heart in diabetes), *mhc* isoform switching occurs. Glucose sensing may be the common mechanism. In addition to the *mhc* isoforms, the expression of various other genes is altered in the above situations. For example, skeletal α-actin is induced during pressure overload, an effect that is abolished when substrate switching is prevented ([@b45-grsb-2007-251]) ([Fig. 3E](#f3-grsb-2007-251){ref-type="fig"}). Furthermore, induction of skeletal α-actin during pressure overload is dependent on the activation of Sp1, a transcription factor that is known to be activated in response to increased glucose availability in liver ([@b22-grsb-2007-251]). More recently the nuclear receptor LXR has been identified as a glucose sensor in the lever as well ([@b27-grsb-2007-251]). In this tissue, LXR serves as a switch for the integration of various metabolic pathways.

While fatty acids are able to modulate gene expression in the heart, most likely through activation of the nuclear receptor PPARα, ([@b2-grsb-2007-251]) nothing is known concerning glucose-regulated gene expression in the heart. Extensive work in liver suggests the involvement of two major pathways in the sensing of glucose availability, namely the hexosamine biosynthetic pathway and the pentose phosphate pathway ([@b16-grsb-2007-251]; [@b14-grsb-2007-251]; [@b40-grsb-2007-251]). The present studies provide evidence that glucose sensing occurs in the heart.

Hexosamine biosynthetic pathway
-------------------------------

Increased influx of glucose into the cell, and/or increased activity of GFAT, results in increased flux through the hexosamine biosynthetic pathway ([@b19-grsb-2007-251]). The resultant elevation in the principal end-product of this pathway, UDP-N-acetylglucosamine, is utilized by transferases for the O-linked glycosylation of various target proteins ([@b42-grsb-2007-251]). Such O-linked glycosylation of signaling proteins occurs at serine and threonine residues otherwise utilized as regulatory phosphorylation sites, a mechanism similar to phosphorylation in that it is a reversible covalent modification that affects the activity of the target protein ([@b42-grsb-2007-251]). However, unlike phosphorylation, the rate of O-linked glycosylation is dependent on intracellular levels of the linkage group donor (i.e. UDP-N-acetylglucosamine, which in turn is dependent upon the influx of glucose into the cell, and/or increased activity of GFAT).

Proteins known to be activated by O-linked glycosylation include the transcription factors c-myc and Sp1, both of which are activated during pressure overload ([@b22-grsb-2007-251]; [@b42-grsb-2007-251]; [@b20-grsb-2007-251]). O-glycosylation of Sp1 is already known for quite some time ([@b21-grsb-2007-251]). The present study shows that UDP-N-acetylglucosamine levels were significantly elevated in pressure overloaded hearts ([Fig. 4C](#f4-grsb-2007-251){ref-type="fig"}). It is reasonable to assume that this increase is due to both increased expression of *gfat2* ([Fig. 4B](#f4-grsb-2007-251){ref-type="fig"}), as well as increased influx of glucose into the cell. We speculate that c-myc and/or Sp1 activation in the heart during pressure overload may be due, at least in part, to increased O-linked glycosylation. Thus, altered glucose metabolism would contribute toward early molecular events involved in remodeling of the heart during pressure overload and the return to the fetal gene program ([@b35-grsb-2007-251]; [@b24-grsb-2007-251]; [@b9-grsb-2007-251]; Mercardier et al. 1981; [@b11-grsb-2007-251]; [@b10-grsb-2007-251]).

Pentose phosphate pathway
-------------------------

We have previously shown appreciable flux through the non-oxidative branch of the PPP in the heart ([@b17-grsb-2007-251]). However, neither the expression of key enzymes involved in this pathway (*g6pdh* and *tkl*), nor the levels of xylulose 5-phosphate, were altered in the heart after seven weeks of pressure overload ([Figs. 4D--4F](#f4-grsb-2007-251){ref-type="fig"}). This suggests that the pentose phosphate pathway may not play a major role in adaptation of the heart to sustained pressure overload. Still, this pathway may be important for acute adaptation to stimuli such as ischemia, when glycolytic intermediates accumulate rapidly. It is certainly important in the liver, where the signaling molecule xylulose 5-phospthate triggers rapid changes in the nuclear import of the transcription factor carbohydrate response element binding protein (ChREBP) which coordinates the transcriptional regulation of metabolic enzymes ([@b39-grsb-2007-251]). The role of ChREBP in the heart remains unknown.

Conclusions
===========

We have found evidence in support of the hypothesis that alterations in metabolism are involved in the adaptation of the heart to environmental stresses, such as pressure overload, at least at the level of gene expression. Increased O-linked glycosylation of proteins may play significant roles in the adaptation of the heart, in addition to transcriptional alterations, such as translational initiation (through eIF-2) or post-translational modulation of enzymatic activity (e.g. glycogen synthase) or cellular signaling (e.g. insulin signaling) ([@b7-grsb-2007-251]; [@b6-grsb-2007-251]; [@b28-grsb-2007-251]). Glucose sensing may therefore play a role in the adaptation of the myocardium to various stimuli, whether they are hemodynamic (e.g. increased workload) or metabolic (e.g. diabetes).
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![Effects of glucose on *mhcα* (**A**) and *mhcβ* (**B**) expression, as well as the *mhcα*/*mhcβ* ratio (**C**), in the perfused working rat heart. Hearts were perfused for 90 minutes in Krebs-Henseleit buffer containing β-hydroxybutyrate (10 mM), acetoacetate (1 mM), propionyl-L-carnitine (2 mM) and insulin (40 μUnits/ml), without (control) or with glucose (25 mM). Control hearts were also perfused in the presence of mannitol (25 mM). Values are shown as the mean ±S.E.M. for four separate observations.\
\*, p \< 0.05.](grsb-2007-251f1){#f1-grsb-2007-251}

![Effects of altered dietary carbohydrate and fat availability on *mhcα* (**A**) and *mhcβ* (**B**) expression, as well as the *mhcα*/*mhcβ* ratio (**C**), in wild-type (WT) and GLUT1 transgenic (Tg) hearts. Mice were placed on either a high carbohydrate/low fat diet (HC/LF) or a low carbohydrate/high fat diet (LC/HF). Values are shown as the mean ± S.E.M. for six separate observations.\
\*, p \< 0.05, and \*\*, p \< 0.01 *versus* WT.](grsb-2007-251f2){#f2-grsb-2007-251}

![Effects of altered dietary carbohydrate and fat availability on *mhcα* (**A**) and *mhcβ* (**B**) expression, the *mhcα*/*mhcβ* ratio (**C**), as well as *bfgf* (**D**) and *sk α-actin* (**E**) expression, in sham and banded (aortic constriction) hearts. Rats were placed on either a high carbohydrate/low fat diet (HC/LF) or a low carbohydrate/high fat diet (LC/HF). Values are shown as the mean ± S.E.M. for five to ten separate observations.\
\*, p \< 0.05; \*\*, p \< 0.01; and \*\*\*, p \< 0.001 *versus* HC/LF sham.](grsb-2007-251f3){#f3-grsb-2007-251}

![Effects of pressure overload on *gfat1* mRNA (**A**), *gfat2* mRNA (**B**) and UDP N-acetyl glucosamine (**C**), *g6pdh* mRNA (**D**), *tkl* mRNA (**E**), and xylulose 5-phosphate (**F**) levels in the heart. Values are shown as the mean ± S.E.M. for six to twenty-four separate observations.\
\*, p \< 0.05 and \*\*\*, p \< 0.001.](grsb-2007-251f4){#f4-grsb-2007-251}

![Hypothetical mechanism of glucose sensing in the heart in response to hemodynamic or metabolic stress. A loss of synchronization between glucose influx into the cardiomyocyte and pyruvate oxidation during pressure overload results in accumulation of glyoclytic intermediates. The latter can cause an increased flux through the pentose phosphate pathway (via G6PDH or TKL) and the hexosamine biosynthethic pathway (via GFAT), resulting in accumulation in xylulose 5-phosphate and UDP N-acetyl glucosamine, respectively. These metabolites affect the activity of various enzymes and transcription factors for phosphorylation and/or glycosylation events.](grsb-2007-251f5){#f5-grsb-2007-251}

###### 

Effects of banding and altered dietary fat content on body weight (BW), heart weight (HW), hypertrophy (HW/BW ratio).

                     HC/LF Sham    HC/LF Banded                                                LC/HF Sham    LC/HF Banded
  ------------------ ------------- ----------------------------------------------------------- ------------- ----------------------------------------------------------
  Body Weight (g)    255 ± 7       257 ± 6                                                     267 ± 6       262 ± 6
  Heart Weight (g)   0.81 ± 0.03   0.99 ± 0.09[\*](#tfn2-grsb-2007-251){ref-type="table-fn"}   0.85 ± 0.02   1.02 ± 0.07[†](#tfn3-grsb-2007-251){ref-type="table-fn"}
  HW/BW (×100)       3.16 ± 0.08   3.91 ± 0.24[\*](#tfn2-grsb-2007-251){ref-type="table-fn"}   3.17 ± 0.07   3.90 ± 0.13[†](#tfn3-grsb-2007-251){ref-type="table-fn"}

Values are shown as the mean ± S.E.M. for between five and ten separate observations.

, p \< 0.05 *versus* HC/LF sham.

, p \< 0.05 *versus* LC/HF banded.

###### 

Primer and probe sequences used in real time quantitative RT-PCR.

  Gene      Primer/Probe   Sequence
  --------- -------------- --------------------------------------------------
  *mhcα*    Forward        5′-TGAAAAGATTAACCGGAGTTTAAGA-3′
            Reverse        5′-CAGGCACGAAGCACTCTGTG-3′
            Probe          5′-FAM-CCIAAGTCAGCCATCTGGGCATC-TAMRA-3′
  *mhcβ*    Forward        5′-TCCTCCCTCAAGCTCCTAAGTAA-3′
            Reverse        5′-TTTGCCTTTGCCCTTGTCTA-3′
            Probe          5′-FAM-CATCAGCICCAGCATAGTTGGCAAACA-TAMRA-3′
  *gfat1*   Forward        5′-GCCGAGCTGTGCAAACTCT-3′
            Reverse        5′-GGCTGCTCAAAAATTTCCTTC-3′
            Probe          5-′FAM-CTCCAGCAGATCATGAAGGGCAACTTTAGT-TAMRA-3′
  *gfat2*   Forward        5′-GCCAGTTCATCTCTCTGGTGC-3′
            Reverse        5′-ATCTGAGGCCACGGATGAT-3′
            Probe          5′-FAM-TGGTTTGATGATGTCTGAAGATCGAATTTCTC-TAMRA-3′
  *g6pdh*   Forward        5′-GGGCAAAGAGATGGTCCAG-3′
            Reverse        5′-TCGATTCCAGATGGGTCCA-3′
            Probe          5′-FAM-AGATCCTGTTGGCAAATCTCAGCACCA-TAMRA-3′
  *tkl*     Forward        5′-CGAAACCCTCACAATGATCG-3′
            Reverse        5′-AGCTTCAGCCCAGACTGCA-3′
            Probe          5′-FAM-TTTGTGCTCTCCAAGGGCCATGC-TAMRA-3′
